A company still losing money, with elevated risk. Institutions are adding.
Facts from SEC filings, not a recommendation.
From ASST's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $6.0M.
Move the sliders to your own view of ASST. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.
SEC filings of any kind. 50 means a normal week.
Institutions added 33.5% to their holdings. 131 bought, 42 sold. 2 quarters of net buying in a row.
| Insider | Trade | Shares | Avg price | Value | Owns after | Date |
|---|---|---|---|---|---|---|
Benjamin PhamChief Financial Officer | Sell | 4K | $31.33 | $132K | 17K | Oct 5Filing ↗ |
| ||||||
Matthew Ryan ColeChief Executive Officer | Sell | 59K | $31.33 | $1.8M | 845K | Oct 5Filing ↗ |
| ||||||
Jonathan R MaceyDirector | Sell | 7K | $30.32 | $203K | 8K | Oct 5Filing ↗ |
| ||||||
James LavishDirector | Sell | 6K | $30.76 | $185K | 9K | Oct 5Filing ↗ |
| ||||||
Brian Logan BeirneChief Legal Officer | Sell | 20K | $31.33 | $629K | 41K | Oct 5Filing ↗ |
| ||||||
Arshia SarkhaniChief Marketing Officer | Sell | 6K | $31.33 | $177K | 12K | Oct 5Filing ↗ |
| ||||||
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page